Roivant Sciences (ROIV) Change in Accured Expenses (2020 - 2025)

Roivant Sciences has reported Change in Accured Expenses for 6 years, with the latest figure at -$3.9 million in Q4 2025.

• For the quarter ending Q4 2025, Change in Accured Expenses rose 80.01% year-over-year to -$3.9 million; the trailing twelve-month figure through Dec 2025 stood at -$35.9 million (up 30.67% YoY), and the FY2024 full-year result was $22.0 million, down 43.59% from the prior year.
• Change in Accured Expenses for Q4 2025 stood at -$3.9 million, down from $12.5 million in the prior quarter.
• The five-year high for Change in Accured Expenses was $37.6 million in Q3 2023, with the low at -$50.0 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged -$1.3 million across 5 years, with a median of -$3.9 million in 2025.
• Annual changes were most pronounced in 2021 — Change in Accured Expenses soared 281.76% — and 2023, when it tumbled 376.83%.
• Roivant Sciences' Change in Accured Expenses stood at $35.6 million in 2021, then slumped by 83.97% to $5.7 million in 2022, then slumped by 376.83% to -$15.8 million in 2023, then decreased by 23.58% to -$19.5 million in 2024, then surged by 80.01% to -$3.9 million in 2025.
• The last three Change in Accured Expenses figures came in at -$3.9 million (Q4 2025), $12.5 million (Q3 2025), and -$25.0 million (Q2 2025), per Business Quant data.